Injective ICO Raised $2,600,000 — BMIC Has Only Raised $530K — Early Opportunity?

Published: 2026-05-27 · Category: DeFi Layer 1

Injective raised $2,600,000 before it became one of the most recognised names in crypto. BMIC has raised just $530,000+ — that's 5x less than Injective raised at a comparable stage.

Lower raise = less market saturation = more room to run. But there's a catch: Injective didn't offer quantum resistance. BMIC does.
🚀 PRESALE LIVE — $0.049

BMIC: The Quantum-Safe Presale — Buy Before TGE Q2 2026

$530K+ raised · 85% APY staking · NIST FIPS 203/204/205 · 186+ media features

Secure Your BMIC Tokens → ⚠️ DYOR. Not financial advice. Crypto investments carry risk.

📊 Head-to-Head: Injective ICO vs BMIC Presale

Injective (INJ) — 2020 ICO

ICO Price$0.33
Total Raised$2,600,000
CategoryDeFi Layer 1
ATH Price$52.0
ATH ROI157x
Current Price$18
Quantum Resistant✗ No

BMIC — Active Presale 2026

Presale Price$0.049
Raised So Far$530K+
CategoryQuantum-Safe L1
Supply1.5B tokens
Staking APY85%
TGEQ2 2026
Quantum Resistant✓ NIST FIPS 203/204/205

💡 The "Low Raise = Opportunity" Logic

When Injective raised $2,600,000, the market had already allocated capital, set expectations, and priced in early momentum. BMIC is sitting at just $530K raised — meaning the vast majority of potential investors haven't even heard of it yet.

The pattern is consistent across major crypto launches:

ProjectICO RaiseATH ROIRaise Year
Ethereum (ETH)$18M15,735x2014
Solana (SOL)$1.76M6,500x2020
Injective (INJ)$2,600,000157x2020
BMIC$530K (LIVE)TGE Q2 20262026

Past performance is not indicative of future results. DYOR.

🔐 The Quantum Advantage Injective Doesn't Have

Why quantum resistance changes everything

📰 Media Coverage: 186+ Features

BMIC has been featured in 186+ media outlets despite raising only $530K. Injective at a comparable raise stage had a fraction of that coverage. Media velocity at this raise size is unusual — and historically a leading indicator of community momentum.

⚡ What Does 85% APY Mean in Practice?

BMIC staking offers 85% APY. At the current presale price of $0.049:

Staked InvestmentTokensAnnual Yield (tokens)Yield Value at $0.049
$50010,2048,673$425
$1,00020,40817,347$850
$5,000102,04186,735$4,250
$10,000204,082173,469$8,500

APY yield valued at presale price. Actual yield value depends on TGE and post-launch price. DYOR.

❓ Frequently Asked Questions

Q: How much did Injective raise in its ICO?
Injective raised $2,600,000 during its 2020 ICO/token sale at a price of $0.33 per token. The project is classified as a DeFi Layer 1.
Q: How much has BMIC raised in its presale?
BMIC has raised $530,000+ in its ongoing presale at $0.049 per token. This is significantly less than most major crypto ICOs, indicating BMIC is at an extremely early stage.
Q: Is BMIC a better investment than Injective was at ICO?
BMIC is at an earlier fundraising stage than Injective was at ICO (Injective: $2,600,000 vs BMIC: $530K). Earlier stage typically means more upside potential — but also more risk. Unlike Injective, BMIC is quantum-resistant (NIST FIPS 203/204/205). This is not financial advice. DYOR.
🚀 PRESALE LIVE — $0.049

BMIC: The Quantum-Safe Presale — Buy Before TGE Q2 2026

$530K+ raised · 85% APY staking · NIST FIPS 203/204/205 · 186+ media features

Secure Your BMIC Tokens → ⚠️ DYOR. Not financial advice. Crypto investments carry risk.